InMed is a bio-pharmaceutical company that specializes in the research, development and commercialization of cannabinoid based pharmaceutical products. We take this class of compounds known as cannabinoids and we formulate these into disease specific products to treat diseases with high unmet medical needs.
Peer-reviewed Publication: Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid system and MAPK signalling pathway
A peer-reviewed scientific study entitled “Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid system and MAPK signalling pathway” has been published in the International
March 13, 2023
